Phio Pharma Stock (NASDAQ:PHIO), Quotes and News Summary

Q: What sector and industry does Phio Pharma (PHIO) operate in?

Phio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Phio Pharma Stock (NASDAQ: PHIO) stock price, news, charts, stock research, profile.

Open	$0.639
Close	-
Volume / Avg.	351.000 / 314.673K
Day Range	0.639 - 0.639
52 Wk Range	0.500 - 12.270
Market Cap	$2.846M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	0.47%
Days to Cover	1

Recent News

Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market trading. Here are some other stocks moving in pre-market trading.

Avi Kapoor

Dow Surges 100 Points; Ciena Posts Upbeat Earnings

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Thursday. The Dow traded up 0.28% to 36,155 while the NASDAQ rose 1.41% to 14,346.47. The S&P 500 also rose, gaining, 0.86% to 4,588.61.

Avi Kapoor

Why Phio Pharmaceuticals Stock Is Nosediving

Phio Pharmaceuticals Corp (NASDAQ: PHIO) shares are trading lower by 40% to $0.95 Thursday afternoon after the company announced it will exercise warrants for $2.8 million in

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Phio Pharmaceuticals Corp

Sector

Health Care

Industry

Biotechnology

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Phio Pharma (PHIO) stock?

You can purchase shares of Phio Pharma (NASDAQ: PHIO) through any online brokerage.

View our list of the best stock brokerages.

Who are Phio Pharma's (PHIO) competitors?

Other companies in Phio Pharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and Finch Therapeutics Gr (NASDAQ:FNCH).

What is the target price for Phio Pharma (PHIO) stock?

The latest price target for Phio Pharma (NASDAQ: PHIO) was reported by HC Wainwright & Co. on Tuesday, February 6, 2024. The analyst firm set a price target for 4.00 expecting PHIO to rise to within 12 months (a possible 545.27% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Phio Pharma (PHIO)?

The stock price for Phio Pharma (NASDAQ: PHIO) is $0.6199 last updated April 18, 2024 at 7:45 AM EDT.

Does Phio Pharma (PHIO) pay a dividend?

There are no upcoming dividends for Phio Pharma.

When is Phio Pharma (NASDAQ:PHIO) reporting earnings?

Phio Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Phio Pharma (PHIO) going to split?

There is no upcoming split for Phio Pharma.

What sector and industry does Phio Pharma (PHIO) operate in?

Phio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-